Yuvraj

Orphan Drugs

The Orphan Drugs Market is set to Rise as a Result of Pharma Companies now Looking to Orphan Drugs as an Essential Revenue Stream...

Bionetworks

Bionetworks: reviewing the various collaborations between pharma, biotech, academia and venture capitalists As many pharmaceutical companies’ needs for growing their pipelines rise, this is fuelling the increase...

Can-Fite Reports First Quarter 2014 Results

Can-Fite BioPharma Ltd. , a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, today reported financial...

China Nepstar Chain Drugstore Ltd. Reports First Quarter 2014 Financial Results

China Nepstar Chain Drugstore Ltd., a leading retail drugstore chain in China based on the number of directly operated stores, today announced its unaudited...

VA’S CONVOLUTED PATIENT SCHEDULING STARTS WITH A ‘HELPLINE’ CALL

Veterans trying to schedule medical appointments in the Veterans Affairs Department’s Phoenix Health Care System entered a Kafkaesque world where they had to call...

Polyplus-transfection launches a new transfection reagent for bioproduction

Polyplus-transfection SA, a privately-held company specializing in the development of innovative solutions for transfection, today announces the launch of FectoPRO(TM), the latest optimised transfection...

Domain Therapeutics appoints Dr Youssef L. Bennani as chairman of the board

Domain Therapeutics, a biopharmaceutical company specializing in the research and development of new drug candidates targeting G protein-coupled receptors (GPCRs), today announces the nomination...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read